We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
28 hedge funds and large institutions have $114M invested in Crescent Biopharma in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
14% more capital invested
Capital invested by funds: $100M → $114M (+$14.3M)
0% more funds holding
Funds holding: 28 → 28 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
10
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
MSA
Mason Street Advisors
Milwaukee,
Wisconsin
|
-$734K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$658K |
| 3 |
JP Morgan Chase
New York
|
-$195K |
| 4 |
Goldman Sachs
New York
|
-$125K |
| 5 |
Blackstone Inc
New York
|
-$119K |
